论文信息 - Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample Collection. - 字舞流文

Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample Collection.

M. Routbort | K. Patel | Kristen C. Floyd | C. Dinardo | R. Kanagal-Shamanna | L. Medeiros | C. Yin | R. Luthra | R. Ruiz-Cordero | S. Loghavi | H. Khogeer | B. Barkoh | Z. Zuo | L. Medeiros | J. Galbincea | C. Ok | Wei Chen | David Hatfield | Sergio Rodriguez | C. DiNardo | Courtney D. DiNardo | Sanam Loghavi

[1] A. Wei,et al. Midostaurin, enasidenib, CPX-351, gemtuzumab ozogamicin, and venetoclax bring new hope to AML. , 2017, Blood.

[2] Esther S. Kim,et al. Enasidenib: First Global Approval , 2017, Drugs.

[3] Carme Camps,et al. Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service , 2017, PLoS medicine.

[4] C. Dinardo,et al. Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-120. , 2016, Clinical lymphoma, myeloma & leukemia.

[5] J. Aster,et al. Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies. , 2016, The Journal of molecular diagnostics : JMD.

[6] Nicola D. Roberts,et al. Genomic Classification and Prognosis in Acute Myeloid Leukemia. , 2016, The New England journal of medicine.

[7] Rakesh Nagarajan,et al. Clinical next‐generation sequencing in patients with non–small cell lung cancer , 2015, Cancer.

[8] H. Kantarjian,et al. Next-generation sequencing-based multigene mutational screening for acute myeloid leukemia using MiSeq: applicability for diagnostics and disease monitoring , 2014, Haematologica.

[9] M. Stratton,et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. , 2013, Blood.

[10] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration , 2012, Briefings Bioinform..

[11] Elaine R. Mardis,et al. A decade’s perspective on DNA sequencing technology , 2011, Nature.

[12] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.

[13] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[14] E. Mardis. Next-generation DNA sequencing methods. , 2008, Annual review of genomics and human genetics.

[15] N. Shinton. WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues , 2007 .

[16] E. Stein,et al. Enasidenib, a targeted inhibitor of mutant IDH2 proteins for treatment of relapsed or refractory acute myeloid leukemia. , 2018, Future oncology.

[17] E. Campo,et al. The World Health Organization Classification of Lymphoid Neoplasms , 2013 .